Ausgabe 11/2006
Inhalt (7 Artikel)
The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness
Yan Zhang, Mei-Yu Hu, Wei-Zhong Wu, Zhi-Jun Wang, Kang Zhou, Xi-Liang Zha, Kang-Da Liu
Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma
G. Treiber, T. Wex, C. Röcken, P. Fostitsch, P. Malfertheiner
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma
Hui Zhang, Qing-Hai Ye, Ning Ren, Lei Zhao, Yan-Fang Wang, Xin Wu, Hui-Chuan Sun, Lu Wang, Bo-Heng Zhang, Yin-Kun Liu, Zhao-You Tang, Lun-Xiu Qin
Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib
Shigenori Kanazawa, Kazuyuki Yamaguchi, Yoshimi Kinoshita, Yutaka Komiyama, Mikiko Muramatsu, Shosaku Nomura
Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer
Andrei Anghel, Marius Raica, Catalin Marian, Sorin Ursoniu, Oana Mitrasca
Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa
Keizo Kato, Akira Hara, Toshiya Kuno, Hideki Mori, Tomomi Yamashita, Makoto Toida, Toshiyuki Shibata
Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy
Thomas J. Vogl, Wolfram Schwarz, Katrin Eichler, Kathrin Hochmuth, Renate Hammerstingl, Ursula Jacob, Albert Scheller, Stephan Zangos, Matthias Heller